Ellen Johnson
Member of Macroaxis Editorial Board
Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
Company Analysis | |
ellen@macroaxis.com | |
Ellen Johnson Latest Stories - Published
Staffing 360 Solutions, trading under the NASDAQ ticker STAF, operates within the Industrials sector, specifically focusing on Staffing & Employment Services. Despite facing challenges, including a quarterly earnings decline of 94% and an EBITDA loss of $10.6 million, the company remains a notable player in its industry. As it explores potential partnerships, such as with Mastech Holdings, investors are keen to see if these strategic moves can turn the tide and enhance profitability.
over a week ago at Macroaxis By Ellen Johnson |
Evogene, a player in the biotechnology sector, has been navigating a challenging financial landscape. With its fiscal year wrapping up in December, the company faces the critical question of whether it can maintain its growth trajectory. Despite generating a total revenue of $5.6 million, Evogene reported a net income loss of $23.9 million, highlighting the financial hurdles it must overcome.
over a week ago at Macroaxis By Ellen Johnson |
Our trading recommendations work alongside the latest insights from analysts and experts on ICICI Bank Limited. By examining a wide range of data—fundamental, technical, and market-related—we assess the bank's growth potential.
Key Points
ICICI Bank's stock, trading at a quote of 29.6, has seen a price percent change of 2.49, indicating a positive momentum that could attract investors looking for growth in the Banks - Regional sector. With an accumulation distribution of 31.4K, the stock shows strong buying interest, suggesting potential for further upward movement.over a month ago at Macroaxis By Ellen Johnson |
Timing is everything, especially when it comes to investing in stocks like IMAC Holdings. As we look toward November, investors are keen to see if IMAC Holdings, trading under the ticker BACK, can offer promising returns. Operating in the healthcare sector, specifically within medical care facilities, IMAC has faced challenges, reflected in its negative earnings per share estimates for the current year at 2.53 and next year at 3.48.
over a month ago at Macroaxis By Ellen Johnson |
By examining the fundamental indicators of Container Store and Tillys, you can assess how market fluctuations impact their stock prices and explore potential risk diversification by including both in your portfolio. Pair trading strategies might be useful here, such as taking a long position in Tillys while shorting Container Store. For more insights, check out our [pair correlation module](#) for detailed analysis.
over a month ago at Macroaxis By Ellen Johnson |
When it rains, it pours, and for investors eyeing JPMorgan Chase, the question is whether the storm has passed or if more clouds are on the horizon. As we step into November, the stock's technical indicators offer a mixed bag of signals. With a 50-day moving average hovering around $211 and a 200-day moving average at approximately $196, the stock is currently trading above both, suggesting a potential bullish trend.
over a month ago at Macroaxis By Ellen Johnson |
Accolade (NASDAQ: ACCD) has recently seen a rise of over 5%, even as the broader market experiences a downturn. This uptick could be attributed to its position within the Health Care Technology sector, which often garners investor interest during volatile times. Despite a challenging earnings landscape, with an EPS estimate for the current year showing a loss of 1.21, the stock's potential upside of 8.4% suggests room for growth.
over a month ago at Macroaxis By Ellen Johnson |
Investors in IMAC Holdings (NASDAQ: BACK) are grappling with conflicting fundamentals that may be contributing to the stock's recent decline. The company reported a staggering loss of 2.8M in cash from operating activities, raising concerns about its financial health. With a current valuation of 7.04M and a price-to-book ratio of just 0.54X, the stock appears undervalued, yet the negative earnings per share estimate of 3.48 for the next year casts a shadow over its potential recovery.
over a month ago at Macroaxis By Ellen Johnson |
AAR Corp has recently encountered a notable downturn, raising questions among investors about the potential for a rebound. The company, operating in the Aerospace & Defense sector, reported a loss in its latest fiscal year, which ended in May. With total liabilities reaching $1.6 billion and operating expenses at $280.2 million, the financial landscape appears challenging.
over a month ago at Macroaxis By Ellen Johnson |
In the world of investing, the choices can often feel overwhelming, especially when weighing two intriguing options like IMAC Holdings and InfuSystem Holdings. IMAC Holdings (NASDAQ: BACK) operates in the health care equipment and supplies sector, but it has faced some significant financial hurdles. With a current ratio of 1.18X, the company shows it can cover its short-term liabilities, but the overall picture isn’t rosy.
over a month ago at Macroaxis By Ellen Johnson |
Latest Stories
Recently Published Macroaxis Headlines